Bloomberg - Home Search
Celgene Corp (CELG:US)
update Jan 30
119.16 -1.71 (-1.41%)
TODAY
High 124.29
Low 118.89
Open 119.49
Volume 8129114
Time Jan 30
intra-day chart
52 WEEK SUMMARY
High 124.60
Low 66.85
P/E 46.52
Return +56.86%
Mkt Cap 95.174 B
one year chart
Company News
Company Profile
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.